Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda

• Status: Completed
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: All

Summary

A randomized double blind control trial to investigate the safety and efficacy of subcutaneous ketamine for control of post operative pain in low resource settings.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Saskatchewan
• Collaborator: National University, Rwanda
• Treatments: Ketamine

Criteria

Inclusion Criteria:

• All patients undergoing upper abdominal, thoracic, gynecologic or orthopaedic surgeries during a one month period with expected post operative hospital admission

Exclusion Criteria:

• Allergy to Ketamine

• History of narcotic abuse or dependence

• Those patients for which decreased cognitive function is a barrier to accurate data collection